BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 761943)

  • 1. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.
    Schirrmacher V; Shantz G; Clauer K; Komitowski D; Zimmermann HP; Lohmann-Matthes ML
    Int J Cancer; 1979 Feb; 23(2):233-44. PubMed ID: 761943
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
    Bosslet K; Schirrmacher V; Shantz G
    Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. 2. Characteristics of a metastasizing variant of a chemically induced lymphoma.
    Schirrmacher V; Shantz G
    Adv Exp Med Biol; 1979; 114():769-75. PubMed ID: 463668
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of host immunological resistance to syngeneic lymphoma using whole body irradiation.
    Maruyama Y
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1159-69. PubMed ID: 993092
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of tumor growth by dinitrochlorobenzene (DNCB).
    Jessup JM; Riggs C; Cohen MH
    Surg Forum; 1976; 27(62):136-7. PubMed ID: 1019830
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.
    Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z
    Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of tumor size and surgical resection on cell-mediated immunity in mice.
    Whitney RB; Levy JG; Smith AG
    J Natl Cancer Inst; 1974 Jul; 53(1):111-6. PubMed ID: 4835101
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and experimental morphologic parameters predictive of tumor metastasis.
    Crissman JD; Hatfield JS; Honn KV
    Prog Clin Biol Res; 1986; 212():251-67. PubMed ID: 3714731
    [No Abstract]   [Full Text] [Related]  

  • 16. Invasion of lymphosarcoma cells into the perfused mouse liver.
    Roos E; Dingemans KP; van de Pavert IV; van den Bergh-Weerman M
    J Natl Cancer Inst; 1977 Feb; 58(2):399-407. PubMed ID: 576239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VII. Interaction of metastasizing and nonmetastasizing tumors with normal tissue in vitro.
    Lohmann-Matthes ML; Schleich A; Shantz G; Schirrmacher V
    J Natl Cancer Inst; 1980 Jun; 64(6):1413-25. PubMed ID: 6929378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor progression and homeostasis.
    Prehn RT
    Adv Cancer Res; 1976; 23():203-36. PubMed ID: 775933
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.